Skip to main content

Table 1 General characteristics of the PCC patients

From: Insights from a retrospective study: an understanding of pediatric colorectal carcinoma

Subject

Early surgical intervention

Late surgical intervention

1

2

3

4

5

6

Adenocarcinoma hitologic type

signet ring cells

signet ring cells

signet ring cells

signet ring cells

signet ring cells

Well differenciated

Age (years)

17

17

16

16

16

14

Gender

M

M

F

M

M

F

Time of evolution (days)a

15

34

15

35

15

63

Symptoms

Anemia, pain, hematochezia, signs of acute abdomen

Anemia, pain, hematochezia, signs of acute abdomen

Anemia, pain, signs of acute abdomen

Anemia, pain, hematochezia

Anemia, dolor, hematoquezia

Anemia, pain, hematochezia

Image study

CTb

CTç

Colonoscopy

PET-CT

Abdominal ultrasound

CTç

CTç

PET-CT

Panesdocopy

CTç

MRCP

Abdominal ultrasound

CT ç

MRCP

Coaxial hepatic biopsy

Colonoscopy

The primary site of the tumor

Descending colon and rectosigmoid junction

Ascending colon

Descending colon

Descending colon and rectosigmoid junction

Descending colon

Rectosigmoid junction and appendix

Metástasis

Peritoneal carcinomatosis and regional lymph nodes

Regional lymph nodes, hepatic, bone, and peritoneal carcinomatosis

Distal lymph nodes, ascending colon, peritoneal carcinomatosis

Peritoneal carcinomatosis, transverse colon, regional lymph nodes, and jejunum

Peritoneal carcinomatosis and regional lymph nodes, duodenum, pancreas, spleen, and transverse colon

Regional lymph nodes, hepatic, and bone

Treatment

Early surgeryc

Laparotomy and biopsy

Laparotomy and biopsy

Laparotomy and appendectomy

No

No

No

Late surgeryd

Laparotomy for tumor obstruction and ileostomy

Laparotomy, left hemicolectomy, colostomy

No

Laparotomy for tumor obstruction and ileostomy

Laparotomy, left hemicolectomy, tumoral resection, colostomy

No

Chemotherapy

Adyuvant

Adjuvant

Neoadjuvant

Adjuvant

Ajuvant

Neoadjuvant

Inmunomoduladores

Yes

No

No

Yes

No

No

Evolution (months)e

15

14

5

12

15

2

  1. F female, M male
  2. aTime since the first symptom was detected by the patient in the initial interrogatory
  3. bcomputed tomography from the thorax, abdomen, and pelvis with contrast. PET CT positron emission computed tomography, MRCP magnetic resonance cholangiopancreatography
  4. cPatients with an initial surgery because of the presentation at admission of acute abdomen
  5. dPatients with no acute abdomen symptoms and did not have surgery at admission
  6. eTime from the first hospital admission until death